Avastin® (bevacizumab) | Official Patient & Caregiver Website

- avastin.com

Learn about Avastin (bevacizumab) solution for IV infusion, including benefits & risks, possible side effects, patient support, and options for financial help. Glioblastoma (GBM) Avastin is approved to treat glioblastoma (GBM) when taken alone in adult patients whose cancer has progressed after prior treatment...

  1,253,635   $ 480.00

Lucentis® (ranibizumab injection) for Wet AMD, DME & RVO

- lucentis.com

Discover Lucentis® (ranibizumab injection), a prescription medicine for the treatment of patients with wet age-related macular degeneration (wet AMD), diabetic macular edema (DME), and macular edema following retinal vein occlusion (RVO). Who is LUCENTIS for? LUCENTIS® (ranibizumab injection) is a prescription...

  1,756,108   $ 480.00

Retina Eye Exam for Preventing Vision Loss from Diabetes | Diabetes Eye Check

- diabeteseyecheck.org

Learn how diabetes can lead to vision loss and what yearly retina eye exams can do to help.

  5,057,300   $ 240.00

My Transplant Life

- mytransplantlife.com

  Not Applicable   $ 8.95

Genentech

- perjetapi.com

Breakthrough science. One moment, one day, one person at a time.

  Not Applicable   $ 8.95

Genentech

- commonclaimsmistakesvideo.com

Breakthrough science. One moment, one day, one person at a time.

  Not Applicable   $ 8.95

Multiple Sclerosis | Care Management

- caremanagersmsguide.com

Learn how care managers can help people living with multiple sclerosis (MS).

  Not Applicable   $ 8.95

Rituxan GPA & MPA Patient

- rituxanforgpampa.com

Rituxan® (Rituximab) is indicated for the treatment of patients with: Relapsed or refractory, low-grade or follicular, CD20-positive, B-cell NHL as a single agent, Previously untreated follicular, CD20-positive, B-cell NHL in combination with first-line chemotherapy and, in patients achieving a complete or partial...

  10,467,497   $ 8.95

Advanced Lung Cancer Immunotherapy Treatment | TECENTRIQ® (atezolizumab)

- patient-therapy-nsclc.com

Find information about TECENTRIQ® (atezolizumab), which is now approved for a type of metastatic non-small cell lung cancer (NSCLC). See full safety for more information.

  Not Applicable   $ 8.95

Roche - Doing now what patients need next

- ang-tie-pathway-hcp.com

As a pioneer in healthcare, we have been committed to improving lives since the company was founded in 1896 in Basel, Switzerland. Today, Roche creates innovative medicines and diagnostic tests that help millions of patients globally.

  Not Applicable   $ 8.95